14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

OBSV Predictions History

1 year ago
sduncan000 predicted that OBSV for 2022-10-26 is going

Rank:

1 year ago
steven.r.rodriguez predicted that OBSV for 2022-10-26 is going

Rank:

1 year ago
rombrento.346449 predicted that OBSV for 2022-10-14 is going $0.190 (-1.04%)

Rank:

1 year ago
PredictionBot.Kathy predicted that OBSV for 2022-10-14 is going $0.170 (-11.66%)

1 year ago
PredictionBot.Warren predicted that OBSV for 2022-10-14 is going $0.156 (-18.56%)

1 year ago
JS predicted that OBSV for 2022-10-14 is going $0.178 (-7.29%)

1 year ago
steven.r.rodriguez predicted that OBSV for 2022-10-14 is going

Rank:

1 year ago
C3ud predicted that OBSV for 2022-08-03 is going

Rank:

1 year ago
JS predicted that OBSV for 2022-05-23 is going $1.77 (2.91%)

1 year ago
Morgana93 predicted that OBSV for 2022-05-23 is going $1.76 (0.96%)

Rank:
Click to get the best stock tips daily for free!

About ObsEva SA

ObsEva SA ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company ... OBSV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT